Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GB1211 |
Trade Name | |
Synonyms | GB-1211|GB 1211 |
Drug Descriptions |
GB1211 inhibits galectin-3 and facilitates the binding of anti-PD-1/PD-L1 antibodies to PD-1/PD-L1 respectively, potentially leading to decreased anti-PD-1/PD-L1 resistance (J Clin Oncol 40, no. 16_suppl (June 01, 2022) 2607-2607). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + GB1211 | Atezolizumab GB1211 | 0 | 1 |
GB1211 | GB1211 | 0 | 0 |
GB1211 + Pembrolizumab | GB1211 Pembrolizumab | 0 | 1 |